- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-2-mer
- Ligands
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.19: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.20: 5 residues within 4Å:- Chain A: N.122, A.123, T.124, N.125, V.127
Ligand excluded by PLIPNAG.21: 3 residues within 4Å:- Chain A: E.132, N.164, N.165
Ligand excluded by PLIPNAG.22: 4 residues within 4Å:- Chain A: T.108, N.234, T.236
- Chain C: E.465
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain A: N.280, E.281, N.282
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain A: N.331, Q.580
Ligand excluded by PLIPNAG.25: 5 residues within 4Å:- Chain A: F.338, G.339, F.342, N.343, L.368
Ligand excluded by PLIPNAG.26: 3 residues within 4Å:- Chain A: N.709, G.1131
- Chain B: D.796
Ligand excluded by PLIPNAG.27: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.28: 5 residues within 4Å:- Chain B: N.122, T.124, N.125, V.127, F.157
Ligand excluded by PLIPNAG.29: 3 residues within 4Å:- Chain B: E.132, N.164, N.165
Ligand excluded by PLIPNAG.30: 3 residues within 4Å:- Chain B: T.108, N.234, T.236
Ligand excluded by PLIPNAG.31: 2 residues within 4Å:- Chain B: N.280, N.282
Ligand excluded by PLIPNAG.32: 2 residues within 4Å:- Chain B: N.331, Q.580
Ligand excluded by PLIPNAG.33: 5 residues within 4Å:- Chain B: F.338, G.339, F.342, N.343, L.368
Ligand excluded by PLIPNAG.34: 4 residues within 4Å:- Chain B: N.709, I.1130, G.1131
- Chain C: D.796
Ligand excluded by PLIPNAG.35: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.36: 4 residues within 4Å:- Chain C: N.122, T.124, V.127, F.157
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain C: E.132, N.164, N.165
Ligand excluded by PLIPNAG.38: 3 residues within 4Å:- Chain C: T.108, N.234, T.236
Ligand excluded by PLIPNAG.39: 3 residues within 4Å:- Chain C: N.280, E.281, N.282
Ligand excluded by PLIPNAG.40: 3 residues within 4Å:- Chain C: N.331, P.579, Q.580
Ligand excluded by PLIPNAG.41: 3 residues within 4Å:- Chain C: F.338, G.339, N.343
Ligand excluded by PLIPNAG.42: 3 residues within 4Å:- Chain A: D.796
- Chain C: N.709, G.1131
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhu, X. et al., Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies. Plos Biol. (2021)
- Release Date
- 2021-05-12
- Peptides
- Spike glycoprotein: ABC
Fab ab1 Heavy Chain: DF
Fab ab1 Light Chain: EG - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DF
FE
EG
G
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-2-2-mer
- Ligands
- 18 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhu, X. et al., Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies. Plos Biol. (2021)
- Release Date
- 2021-05-12
- Peptides
- Spike glycoprotein: ABC
Fab ab1 Heavy Chain: DF
Fab ab1 Light Chain: EG - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DF
FE
EG
G